Malvi Thakker
Internal Medicine · Bayside, NYNPI 1689106130
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 15th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 13 | $110,944 |
| AranespDarbepoetin Alfa In Polysorbat | 17 | $57,704 |
| EliquisApixaban | 22 | $23,670 |
| XareltoRivaroxaban | 12 | $17,709 |
| Imatinib Mesylate | 11 | $877 |
| Hydroxyurea | 19 | $209 |
| LoperamideLoperamide Hcl | 11 | $190 |
| Potassium Chloride | 14 | $117 |
| Allopurinol | 19 | $65 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bayside
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.